Caxton Associates (New York)’s Idexx Laboratories IDXX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-927	Closed	-$501K	–	536
2024 Q1	$501K	Buy	+927	New	+$507K	0.03%	322
2023 Q4	–	Sell	-3,911	Closed	-$1.71M	–	500
2023 Q3	$1.71M	Sell	3,911 -362	-8%	-$181K	0.24%	71
2023 Q2	$2.15M	Buy	4,273 +2,927	+217%	+$1.4M	0.32%	62
2023 Q1	$673K	Buy	+1,346	New	+$644K	0.11%	215
2022 Q4	–	Sell	-4,823	Closed	-$1.57M	–	528
2022 Q3	$1.57M	Buy	4,823 +2,948	+157%	+$1.08M	0.27%	45
2022 Q2	$658K	Buy	+1,875	New	+$765K	0.08%	206
2022 Q1	–	Sell	-478	Closed	-$315K	–	604
2021 Q4	$315K	Buy	+478	New	+$300K	0.04%	403
2021 Q2	–	Sell	-1,066	Closed	-$522K	–	535
2021 Q1	$522K	Buy	+1,066	New	+$534K	0.05%	154
2019 Q3	–	Sell	-33,794	Closed	-$9.3M	–	466
2019 Q2	$9.3M	Buy	33,794 +31,178	+1,192%	+$7.68M	1.24%	16
2019 Q1	$585K	Buy	2,616 +724	+38%	+$149K	0.1%	123
2018 Q4	$352K	Hold	1,892	–	–	0.07%	165
2018 Q3	$472K	Buy	+1,892	New	+$459K	0.05%	241
2017 Q4	–	Sell	-1,700	Closed	-$264K	–	431
2017 Q3	$264K	Sell	1,700 -900	-35%	-$142K	0.02%	451
2017 Q2	$420K	Buy	+2,600	New	+$422K	0.03%	390